Table 3.
Men | Women | ||||||||
---|---|---|---|---|---|---|---|---|---|
Inactive at 36, active at 60 to 64 | Active at 36, inactive at 60 to 64 | Active at both ages | p value* | Inactive at 36, active at 60 to 64 | Active at 36, inactive at 60 to 64 | Active at both ages | p Value* | p Sex int | |
% diff (95% CI) | % diff (95% CI) | % diff (95% CI) | % diff (95% CI) | % diff (95% CI) | % diff (95% CI) | ||||
Trabecular radius vBMD | |||||||||
N, men = 584; women = 616 | |||||||||
Model 1 | −0.83 (−9.30 to 7.63) | 3.87 (−0.71 to 8.45) | 8.74 (4.07 to 13.42) | 0.0001 | −3.68 (−11.02 to 3.67) | −2.11 (−7.78 to 3.55) | −3.99 (−9.66 to 1.68) | 0.550 | 0.007 |
Model 2 b | −0.61 (−9.03 to 7.82) | 3.37 (−1.19 to 7.93) | 8.64 (4.00 to 13.29) | 0.0001 | −1.43 (−8.84 to 5.98) d 0.52 (0.02 to 1.01) e | −0.52 (−6.31 to 5.28) d 0.30 (‐0.06 to 0.66) e | −0.86 (−6.72 to 4.99) d 0.70 (0.29 to 1.11) e | 0.980 0.006** | 0.028*** |
Model 3 b , c | −1.49 (−10.01 to 7.03) | 3.08 (−1.50 to 7.67) | 8.06 (3.30 to 12.82) | 0.003 | −2.31 (−9.77 to 5.16) d , f | −0.89 (−6.70 to 4.93) d , f | −1.70 (−7.67 to 4.27) d , f | 0.92 | 0.007*** |
0.48 (−0.02 to 0.97) e | 0.29 (−0.08 to 0.65) e | 0.72 (0.31 to 1.14) e | 0.005** | ||||||
Total density vBMD | |||||||||
N, men = 586; women = 617 | |||||||||
Model 1 | −5.90 (−12.79 to 0.99) | −1.26 (−4.98 to 2.46) | −1.46 (−5.26 to 2.34) | 0.41 | 1.55 (−4.43 to 7.53) | −2.42 (−7.03 to 2.19) | −2.62 (−7.24 to 1.99) | 0.380 | 0.29 |
Model 2 | −5.77 (−12.67 to 1.13) | −1.43 (−5.17 to 2.30) | −1.49 (−5.29 to 2.31) | 0.43 | 4.54 (−1.49 to 10.57) | 0.17 (−4.50 to 4.84) | 0.47 (−4.28 to 5.21) | 0.43 | 0.28 |
Model 3 c | −6.66 (−13.64 to 0.32) | −1.71 (−5.45 to 2.04) | −2.15 (−6.04 to 1.75) | 0.29 | 4.22 (−1.88 to 10.32) | 0.24 (−4.45 to 4.93) | 0.34 (−4.53 to 5.21) | 0.51 | 0.28 |
Hip aBMD | |||||||||
N, men = 691; women = 769 | |||||||||
Model 1 | 0.81 (−4.53 to 6.15) | 4.51 (1.63 to 7.39) | 3.41 (0.48 to 6.35) | 0.016 | −1.18 (−5.01 to 2.64) | 0.27 (−2.57 to 3.11) | −1.08 (−3.93 to 1.77) | 0.710 | 0.13 |
Model 2 b | −0.49 (−5.22 to 4.25) | 3.20 (0.64 to 5.75) | 2.87 (0.27 to 5.47) | 0.04 | −1.18 (−2.18 to 4.54) d | 1.76 (−0.76 to 4.28) d | 2.79 (0.24 to 5.34) d | 0.19 | 0.008*** |
0.21 (−0.02 to 0.43) e | 0.16 (0.003 to 0.32) e | 0.37 (0.20 to 0.55) e | 0.001** | ||||||
Model 3 b , c | −0.45 (−5.23 to 4.33) | 3.33 (0.77 to 5.90) | 3.04 (0.39 to 5.69) | 0.03 | 0.42 (−2.94 to 3.77) d , f | 1.46 (−1.05 to 3.96) d , f | 2.00 (−0.59 to 4.59) d , f | 0.43 | 0.009*** |
0.19 (−0.03 to 0.42) e | 0.14 (−0.02 to 0.29) e | 0.37 (0.19 to 0.54) e | 0.001** | ||||||
Spine L1 to L4 aBMD | |||||||||
N, men = 698; women = 774 | |||||||||
Model 1 | −3.35 (−9.59 to 2.88) | 2.33 (−1.03 to 5.68) | 3.41 (−0.004 to 6.83) | 0.06 | −2.25 (−6.66 to 2.16) | −1.10 (−4.39 to 2.18) | −0.94 (−4.24 to 2.37) | 0.780 | 0.2 |
Model 2 | −4.48 (−10.42 to 1.46) | 1.37 (−1.83 to 4.57) | 3.00 (−0.25 to 6.25) | 0.04 | −0.54 (−4.78 to 3.69) | 0.07 (−3.11 to 3.25) | 1.57 (−1.65 to 4.79) | 0.64 | 0.46 |
Model 3 c | −3.96 (−9.97 to 2.05) | 1.67 (−1.55 to 4.89) | 3.33 (0.02 to 6.65) | 0.04 | −1.37 (−5.60 to 2.87) | −0.29 (−3.46 to 2.88) | 1.14 (−2.15 to 4.42) | 0.61 | 0.5 |
vBMD = volumetric bone mineral density; areal bone mineral density = areal bone mineral density.
Model 1: unadjusted; Model 2: current height and weight; Model 3: model 2 + current smoking status, occupational class and long‐term illness.
In women, interaction between change in LTPA x weight p ≤ 0.01.
In women, same adjustments as for men plus type and timing of menopause.
Effect estimate for women of mean weight (72.3 kg).
Change in LTPA x weight interaction term.
Estimates at the 25th (62.8 kg) and 75th (80.2 kg) percentiles are illustrated in Supplemental Fig. 1.
*p value for overall test of association.
**p value for interaction between change in LTPA and weight.
***p value for change in LTPA x weight x sex.